Fig. 1From: A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infectionPatient disposition. AE adverse event, LPVPS last post-therapy follow-up visit of the parent study, SVR sustained virologic responseBack to article page